HOUSTON and VANCOUVER, BC – ESSA Pharma Inc. (NASDAQ: EPIX) (“ESSA” or the “Company”), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced the first patient… Read More
Taking brain research in promising new directions is at the heart of a new Simon Fraser University (SFU) research institute, to be led by renowned neuroscientist Randy McIntosh. The SFU… Read More
Merck Allocates 3 Million Courses of Molnupiravir to be Provided in First Half of 2022 for Use in Low- and Middle-Income Countries KENILWORTH, N.J. & MIAMI – Merck (NYSE: MRK),… Read More
Applications are now open for entrepreneurship@UBC’s Spring 2022 Venture Founder, Lab2Launch cohort! Open House Week Learn more by attending our online ‘Open House Week’ January 17th to 21st featuring three events… Read More
VANCOUVER, B.C. – Acuitas Therapeutics is proud to announce a multi-year sponsorship agreement with Vancouver Athletic Football Club (VAFC). This sponsorship will allow the club to expand their training resources… Read More
